To prevent anastomotic leakage (AL) and to reduce its clinical consequences, diverting stomas are often constructed during index rectal cancer surgery. While this approach decreases short-term incidence of symptomatic AL, a subclinical leak can still develop and might become symptomatic at a later stage
1,2. In the case of primarily non-diverted symptomatic AL, secondary faecal diversion is the mainstay of treatment
3. Several weeks or months after index surgery, the anastomosis is assessed using endoscopic and/or radiological examination. If healing is confirmed, the diverting stoma is usually closed. However, some patients might develop a symptomatic AL within weeks to even years thereafter, which is also referred to as reactivation leakage.